AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Assessing the Effectiveness of Heat Adaptation Digital Messages From Primary Care Providers to Their Patients on the Change in Behaviour for Heatwave-related Preparedness

RecruitingNAAges 18 Years - anyAllHopital Montfort
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Extreme heat events pose a significant health threat in Canada, as demonstrated by the 2021 heat wave that claimed over 600 lives in Western Canada. Most heat-related deaths occur indoors and are preventable. Primary care providers (PCPs), who serve 88% of Canadians, are uniquely positioned to identify and support at-risk individuals. Heat Smart, in alignment with Heat Alert and Response Systems (HARS), aims to bridge the gap between primary care and public health to enhance community resilience and reduce health inequities related to extreme heat events. This randomized control trial in Eastern Ontario will examine whether patients receiving tailored digital health messages from their family physician or nurse practitioner change their behaviour to protect themselves from extreme heat-related illness. The Heat Smart study will: * Assess risk: Analyze electronic medical records and pat

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: The Heat Smart randomized controlled trial study will recruit patients and primary care providers (PCPs) from Eastern Ontario. The inclusion criteria ensure that the intervention reaches at-risk individuals while being scalable across different patient populations: Primary Care Patients: * Adults (18 years and older) * Patients must be registered with a participating PCP. * They must have had at least one visit with their PCP in the past two years to ensure active engagement. * Participants must have an active email, cell phone or messaging service (SMS) to receive Heat Smart digital messages. * Patients must be able to understand and consent to participate in the study. * Patients must be able to communicate in at least one of the official languages (English, French). * Participants will be recruited from PCP located in two Eastern Ontario public health districts: the Eastern Ontario Health Unit and Ottawa Public Health (including urban, rural, and Indigenous communities such as Akwesasne). Primary Care Providers: * Must be a licensed Family Physician (FP) or Nurse Practitioner (NP) in a practice of at least 2 PCPS. * The providers must be offering comprehensive primary care to a panel of patients (not solely urgent care or walk-in services). * Must work in a computerized primary care clinic with an electronic medical record system. * Must expect to remain in practice for at least 24 months. * Must be located in Eastern Ontario. * Must be willing to use the Canadian Primary Care Information Network (CPIN) to deliver Heat Smart messages and surveys. * Must be using Cliniconex or Qualtrics as a practice tool for communication enabling outreach before the patients are invited to consent to participate in the study. Exclusion Criteria: Patients who do not read French or English will be excluded from the study as they will not be able to give informed consent or to fill out the surveys. Patients who do not have an email address or text messaging service will be excluded for the same reason. Minors, patients with dementia and people who cannot read and write in English or French will not be eligible because the automated approach to surveying patients makes it impractical to properly obtain their consent.
๐Ÿ’Š

What it tests

  • Heat adaptation digital messaging
  • Non-heat-related digital messaging
๐Ÿ“

Where

1 site
Institut du Savoir Montfort
Ottawa, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy